Nintedanib Esylate

Nintedanib Esylate in-domus specification.DMF praesto est.

CAS:656247-18-6

Model:656247-18-6

Mitte Inquisitionem

depictio producti

CAS Numberï¼656247-18-6

Formulae hypotheticaeï¼C₃₁H₃₃N₅O₄.C₂H₆O₃S
M. Pondusï¼649.75706

Notitia generali

Nintedanib Esylate, moleculae tyrosinae kinasi inhibitoris TKI oritur ex novo studio pro curatione IPF.

Receptatores (PDGF Î± et ), factores receptores fibroblast incrementi endothelialis (FGFR1-3), et vasculares incrementi endothelialis receptatores (VEGFR1-3), certatim ligant ad sitos adenosinos triphosphatos (ATP) ligandos. horum receptorum intercluderent vias significantes processus fibroblast et inhibentes proliferation, metastasis et transformatio fibroblastorum, progressionem IPF morbi retardans.

Ordinationes

Nintedanib Esylatehabet in domo speciem. DMF probatus.

Formulae Available
Capsula

Hot Tags: Nintedanib Esylate, China, Suppliers, Manufacturers, Factory

Product Tag